We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

California Initiative to Advance Precision Medicine Announces Funding for 2 Projects

Two demonstration projects that aim to yield quick results for patients have been selected by the new California Initiative to Advance Precision Medicine, a public-private effort launched by Governor Edmund G. Brown Jr.
News

NSF Awards KSU $1.6M for Wheat Genome Research

Kansas State University wheat researchers are leading efforts to develop a better understanding of the wheat genome.
News

New Biosensors for Managing Microbial ‘Workers’

Researchers at Harvard’s Wyss Institute have unveiled new biosensors that enable scientists to more effectively control and 'communicate with' engineered bacteria.
News

Critical New Insights on DNA Repair

The enzyme fumarase is key to reversing genetic damage leading to cancer and therapy resistance.
News

Environmental Epigenetics Affects Disease, Evolution

Researchers say environmental factors are having an underappreciated effect on the course of disease and evolution by prompting genetic mutations through epigenetics, a process by which genes are turned on and off independent of an organism’s DNA sequence.
News

Study Sheds Light on the Causes of Cerebral Palsy

Wider use of genetic testing in children with CP should be considered.
News

10X Genomics Releases Linked-Read Data from NIST Genome Samples

Genome in a Bottle Consortium data submission for webinar presentation and public availability.
News

Illumina to Acquire GenoLogics

Illumina has signed a definitive agreement to acquire GenoLogics, a developer of LIMS for life science organizations.
News

Rescuing Genetic Material from Formaldehyde Treated Tissue Samples

Formaldehyde is excellent for preserving cellular structures, but it makes it difficult to pull genetic information from tissue samples. Eric Kool and colleagues have developed a catalyst that saves RNA, which could lead to better patient outcomes.
News

New Vaccine For Chlamydia to Use Synthetic Biology

Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Advertisement